A study on the effectiveness of Draksha Ghrita Eye Drops in patients with Dry Eye Disease

An Open-Label Randomized Controlled Clinical Trial to Evaluate the Efficacy of Topical Draksha Ghrita for Treatment of Dry Eye Disease - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/106356

Enrollment

Registered

2026-03-17

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H041- Other disorders of lacrimal gland

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Signed ICF (Informed Consent Form) Patients presenting with signs and symptoms of Dry eye Disease Age group 18-50 years TFBUT (Tear Film Break-up Time)less than or equal to 10 Seconds. CFS (Corneal Fluorescein Staining) Schirmer s test less than 10mm

Exclusion criteria

Exclusion criteria: Cases with any ocular history even in one eye, ocular injury, ocular infection, eyelid disease, lid abnormalities Known allergies Autoimmune disease Patients who use contact lens Other oral steroids, oral cyclosporine, anti glaucoma medication within 60 days before screening Patients suffering from any systemic disorder or taking any medications History of ocular surgery within 6 months prior to enrolment Stevens-Johnson syndrome Sjogren s syndrome Patient who starts developing complications will be excluded from the study Patient not willing for the treatment

Design outcomes

Primary

Measure	Time frame
Change in OSDI score from baseline Timepoint: 30 days	—

Secondary

Measure	Time frame
Change in Tear film breakup time from baseline Timepoint: 30 days;Change in Tear film proteomics from baseline Timepoint: 30 days	—

Countries

India

Contacts

Public ContactAjisha P

Banaras Hindu University

mkumarbhu@gmail.com9793127744

Outcome results